Evidence map›Paper›PMID 34426634›Full record

Trial reportScientific reports2021

Impact of severe hypoglycemia on the heat shock and related protein response.

Alexander S Atkin, Abu Saleh Md Moin, Manjula Nandakumar, Ahmed Al-Qaissi, Thozhukat Sathyapalan, Stephen L Atkin, Alexandra E Butler

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03102801 (A Study to Identify Biomarkers of Hypoglycaemia in Patients With Type 2 Diabetes), which is not on this map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03102801 nacompletednot on this map

A Study to Identify Biomarkers of Hypoglycaemia in Patients With Type 2 Diabetes

TypeinterventionalSponsorUniversity of HullRan2017 to 2018Enrolled50ConditionsType 2 Diabetes Mellitus With HypoglycemiaArmsHumulin S
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Alexander S Atkin *Trinity College, Cambridge University, Cambridge, UK.
Abu Saleh Md Moin *Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box 34110, Doha, Qatar.
Manjula NandakumarDiabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box 34110, Doha, Qatar.
Ahmed Al-QaissiAcademic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, UK.
Thozhukat SathyapalanAcademic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, UK.
Stephen L AtkinRoyal College of Surgeons of Ireland, PO Box 15503, Adliya, Bahrain.
Alexandra E ButlerRoyal College of Surgeons of Ireland, PO Box 15503, Adliya, Bahrain. abutler@rcsi.com.
Hull York Medical School · GBRoyal College of Surgeons in Ireland - Bahrain · BHHamad bin Khalifa University · QAQatar Foundation · QAUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heat shock proteins contribute to diabetes-induced complications and are affected by glycemic control. Our hypothesis was that hypoglycemia-induced heat shock and related protein changes would be amplified in type 2 diabetes (T2D). This prospective, case-control study enrolled 23 T2D patients and 23 control subjects who underwent hyperinsulinemic-induced hypoglycemia (≤ 2.0 mmol/L (36 mg/dl)) with blood sampling at baseline, at hypoglycemia and after a 24-h post-hypoglycemia follow-up period. Proteomic analysis of heat shock-related and pro-inflammatory proteins was performed. At baseline, MAPKAPK5 (p = 0.02) and UBE2G2 (p = 0.003) were elevated and STUB1 decreased (p = 0.007) in T2D. At hypoglycemia: PPP3CA (p < 0.03) was increased and EPHA2 (p = 0.01) reduced in T2D; by contrast, three proteins were reduced in controls [HSPA1A (p = 0.007), HSPB1 (p < 0.02), SMAD3 (p = 0.005)] while only MAPKAPK5 was elevated (p = 0.02). In the post-hypoglycemia follow-up period, most proteins normalized to baseline by 24-h; however, STIP1 (p = 0.003), UBE2N (p = 0.004) and UBE2L3 (p < 0.04) were decreased in controls at 24-h. No protein differed from baseline at 24-h in T2D. Pro-inflammatory interleukin-6 increased at 4-h post-hypoglycemia in controls and T2D (p < 0.05 and p < 0.003, respectively) and correlated with HSPA1A; anti-inflammatory IL-10 decreased 2-h post-hypoglycemia in T2D only. Other pro-inflammatory proteins, IL-1α, IFN-γ and TNF-α, were unchanged. Heat shock and related proteins differed at baseline between T2D and controls, with an exaggerated response of heat shock and related proteins to hypoglycemia that returned to baseline, though with changes at 24-h in controls alone. An increase in pro-inflammatory IL-6, with a decrease in anti-inflammatory IL-10, suggests that the HSP system is overactivated due to underlying inflammation in T2D.Trial registration: ClinicalTrials.gov NCT03102801.

Indexed as

Heat-Shock ResponseAdultAgedDiabetes Mellitus, Type 2FemaleHeat-Shock ProteinsHSP70 Heat-Shock ProteinsHumansHypoglycemiaInterferon-gammaInterleukinsIntracellular Signaling Peptides and ProteinsMaleMiddle AgedMolecular ChaperonesProtein Serine-Threonine KinasesEPHA2 protein, humanHeat-Shock ProteinsHSP70 Heat-Shock ProteinsHSPA1A protein, humanHSPB1 protein, humanInterferon-gammaInterleukinsIntracellular Signaling Peptides and ProteinsMAP-kinase-activated kinase 5Molecular ChaperonesProtein Serine-Threonine KinasesProteomeReceptor, EphA2Smad3 ProteinSMAD3 protein, humanSTUB1 protein, humanTumor Necrosis Factor-alphaUBE2G2 protein, humanUbiquitin-Conjugating EnzymesUbiquitin-Protein Ligases

Identifiers

PMID34426634
PMCPMC8382834
OpenAlexW3194403836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.